Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/oncolytics-biotech-initiates-enrollment-expansion-of-goblet-anal-cancer-cohort-302061219.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-appoints-patricia-s-andrews-to-its-board-of-directors-302029215.html
https://www.prnewswire.com/news-releases/oncolytics-announces-the-anal-cancer-cohort-of-the-goblet-phase-12-study-of-pelareorep-and-atezolizumab-has-met-the-success-criteria-for-efficacy-301983245.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-and-solti-present-further-positive-pelareorep-translational-data-at-sitc-301977019.html
https://www.prnewswire.com/news-releases/oncolytics-presents-positive-updated-pancreatic-cancer-data-from-goblet-phase-12-study-at-esmo-301964264.html
https://www.prnewswire.com/news-releases/oncolytics-achieves-success-criteria-for-efficacy-in-the-third-line-colorectal-cancer-cohort-of-the-goblet-study-301964255.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-to-host-conference-call-to-discuss-third-quarter-financial-results-and-recent-operational-highlights-301962804.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-announces-us15-million-bought-deal-offering-of-units-301889041.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-announces-updated-randomized-phase-2-data-from-bracelet-1-metastatic-breast-cancer-trial-that-show-pelareorep-driving-robust-increases-in-progression-free-survival-and-confirmed-overall-response-rate-301842058.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-to-participate-in-a-panel-presentation-at-canaccord-genuitys-horizons-in-oncology-virtual-conference-301795462.html